• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vaccination against COVID-19 in a haemodialysis centre: what is the risk of bleeding complications?

作者信息

Giot Matthieu, Robert Thomas, Brunet Philippe, Resseguier Noémie, Lano Guillaume

机构信息

Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception AP-HM, Marseille, France.

Unité de Soutien à la Recherche Clinique et à L'évaluation Économique, AP-HM, Marseille, France.

出版信息

Clin Kidney J. 2021 Apr 1;14(6):1701-1703. doi: 10.1093/ckj/sfab059. eCollection 2021 Jun.

DOI:10.1093/ckj/sfab059
PMID:34429940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7989515/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6778/8381339/f2d3aa58aa32/sfab059f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6778/8381339/f2d3aa58aa32/sfab059f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6778/8381339/f2d3aa58aa32/sfab059f1.jpg

相似文献

1
Vaccination against COVID-19 in a haemodialysis centre: what is the risk of bleeding complications?血液透析中心的新冠病毒疫苗接种：出血并发症的风险有哪些？
Clin Kidney J. 2021 Apr 1;14(6):1701-1703. doi: 10.1093/ckj/sfab059. eCollection 2021 Jun.
2
Active immunization against hepatitis B infection of a haemodialysis population.
Natl Med J India. 1994 May-Jun;7(3):115-6.
3
At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis.至少有156个理由让接受中心血液透析的患者优先接种新冠疫苗。
Nephrol Dial Transplant. 2021 Mar 29;36(4):571-574. doi: 10.1093/ndt/gfab007.
4
Hepatitis B vaccination in haemodialysis patients: an underestimated problem. Factors influencing immune responses in ten years of observation in an Italian haemodialysis centre and literature review.血液透析患者的乙肝疫苗接种：一个被低估的问题。意大利一家血液透析中心十年观察中影响免疫反应的因素及文献综述。
Ann Ig. 2017 Jan-Feb;29(1):27-37. doi: 10.7416/ai.2017.2129.
5
Anticoagulation during haemodialysis in patients at high-risk of bleeding.
Nephrology (Carlton). 2003 Oct;8 Suppl:S23-7. doi: 10.1046/j.1440-1797.8.s.3.x.
6
Low-molecular weight heparin infusion as anticoagulation for haemodialysis.低分子量肝素输注用于血液透析抗凝
Clin Kidney J. 2016 Aug;9(4):630-5. doi: 10.1093/ckj/sfw049. Epub 2016 Jun 10.
7
Rationale and design for SHAREHD: a quality improvement collaborative to scale up Shared Haemodialysis Care for patients on centre based haemodialysis.SHAREHD的基本原理与设计：一项质量改进合作项目，旨在扩大为接受中心血液透析的患者提供的共享血液透析护理服务。
BMC Nephrol. 2017 Nov 24;18(1):335. doi: 10.1186/s12882-017-0748-6.
8
A clinical study on the changing dynamics of disease severity, management strategies and outcomes of COVID-19 in patients requiring haemodialysis.一项关于需要血液透析的 COVID-19 患者疾病严重程度、管理策略和结局变化动态的临床研究。
J Nephrol. 2021 Aug;34(4):999-1006. doi: 10.1007/s40620-021-01072-4. Epub 2021 May 29.
9
The anticipated and the lived experience of home and in-centre haemodialysis: Is there a disconnect?家庭血液透析和中心血液透析的预期与实际体验：是否存在脱节？
J Health Psychol. 2017 Oct;22(12):1524-1533. doi: 10.1177/1359105316630135. Epub 2016 Mar 8.
10
Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.附录：透析中心指南：门诊血液透析中心与参考医院之间关系的建议。来自门诊透析组的意见。
Nefrologia. 2011;31(6):664-9. doi: 10.3265/Nefrologia.pre2011.Oct.11001.

引用本文的文献

1
A Study on Mortality Predictors in Hemodialysis Patients Infected with COVID-19: Impact of Vaccination Status.新冠病毒感染的血液透析患者死亡率预测因素研究：疫苗接种状况的影响
Vaccines (Basel). 2023 Dec 19;12(1):2. doi: 10.3390/vaccines12010002.
2
Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19.COVID-19 第一波疫情后血液透析患者及其护理人员体内 SARS-COV2 特异性抗体的存在情况。
Sci Rep. 2022 Jul 13;12(1):11972. doi: 10.1038/s41598-022-15913-0.
3
Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational study.

本文引用的文献

1
The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action.为透析患者接种严重急性呼吸综合征冠状病毒2疫苗的迫切需求：行动呼吁
Kidney Int. 2021 Apr;99(4):791-793. doi: 10.1016/j.kint.2021.02.003. Epub 2021 Feb 12.
2
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort.来自法国多中心队列的慢性透析患者中 COVID-19 严重程度的风险因素。
Clin Kidney J. 2020 Oct 21;13(5):878-888. doi: 10.1093/ckj/sfaa199. eCollection 2020 Oct.
3
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA.
血液透析患者中 ChAd/BNT 异源疫苗与同源 BNT/BNT 和 ChAd/ChAd SARS-CoV-2 疫苗相比的体液免疫原性和耐受性：一项多中心前瞻性观察研究。
J Nephrol. 2022 Jun;35(5):1467-1478. doi: 10.1007/s40620-022-01247-7. Epub 2022 Jan 27.
4
Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients.血液透析患者对新冠疫苗接种的刺突蛋白及中和抗体反应
Clin Kidney J. 2021 Jul 6;14(10):2239-2245. doi: 10.1093/ckj/sfab128. eCollection 2021 Oct.
慢性肾脏病是重症 COVID-19 的一个关键风险因素：ERA-EDTA 的行动呼吁。
Nephrol Dial Transplant. 2021 Jan 1;36(1):87-94. doi: 10.1093/ndt/gfaa314.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration.COVID-19 相关死亡率在肾移植和透析患者：ERACODA 合作的结果。
Nephrol Dial Transplant. 2020 Nov 1;35(11):1973-1983. doi: 10.1093/ndt/gfaa261.
6
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.欧洲透析患者和肾移植受者的 ERA-EDTA 注册中心研究结果表明，他们因 COVID-19 导致的死亡率很高。
Kidney Int. 2020 Dec;98(6):1540-1548. doi: 10.1016/j.kint.2020.09.006. Epub 2020 Oct 15.
7
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.合并慢性肾脏病和心房颤动患者的抗凝治疗：美国心脏病学会评论专题之周更。
J Am Coll Cardiol. 2019 Oct 29;74(17):2204-2215. doi: 10.1016/j.jacc.2019.08.1031.
8
Prevalence of atheromatous and non-atheromatous cardiovascular disease by age in chronic kidney disease.慢性肾脏病患者中动脉粥样硬化性和非动脉粥样硬化性心血管疾病的患病率随年龄增长而变化。
Nephrol Dial Transplant. 2020 May 1;35(5):827-836. doi: 10.1093/ndt/gfy277.
9
Haemostasis in chronic kidney disease.慢性肾脏病的止血治疗。
Nephrol Dial Transplant. 2014 Jan;29(1):29-40. doi: 10.1093/ndt/gft209. Epub 2013 Oct 16.
10
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study.流感疫苗接种与维生素K拮抗剂治疗：一项安慰剂对照、随机、双盲交叉研究。
Arch Intern Med. 2010 Apr 12;170(7):609-16. doi: 10.1001/archinternmed.2010.49.